Introduction: Cross-sectional analyses have associated familial longevity with better cognitive function and lower risk of cognitive impairment in comparison with individuals without familial longevity. The extent to which long-lived families also demonstrate slower rates of cognitive aging (i.e., change in cognition over time) is unknown. This study examined longitudinally collected data among 2 generations of the Long Life Family Study (LLFS) to compare rates of cognitive change across relatives and spouse controls. Methods: We analyzed change in 6 neuropsychological test scores collected approximately 8 years apart among LLFS family members (n = 3,972) versus spouse controls (n = 1,092) using a Bayesian hierarchical model that included age, years of follow-up, sex, education, generation, and field center and all possible pairwise interactions. Results: At a mean age of 88 years at enrollment in the older generation and 60 years in the younger generation, LLFS family members performed better than their spouses on the Digit Symbol Substitution Test (DSST) and the Logical Memory test. At follow-up, family members in the younger generation also showed slower decline than spouses on the DSST, whereas rates of change of Digit Span, fluency, and memory were similar between the 2 groups. Discussion/Conclusion: Individuals in families with longevity appear to have better cognitive performance than their spouses for cognitive processes including psychomotor processing, episodic memory, and retrieval. Additionally, they demonstrate longer cognitive health spans with a slower decline on a multifactorial test of processing speed, a task requiring the integration of processes including organized visual search, working and incidental memory, and graphomotor ability. Long-lived families may be a valuable cohort for studying resilience to cognitive aging.

1.
Roberts
RO
,
Knopman
DS
,
Mielke
MM
,
Cha
RH
,
Pankratz
VS
,
Christianson
TJ
,
Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal
.
Neurology
.
2014 Jan 28
;
82
(
4
):
317
25
. .
2.
Scanlan
JM
,
Binkin
N
,
Michieletto
F
,
Lessig
M
,
Zuhr
E
,
Borson
S
.
Cognitive impairment, chronic disease burden, and functional disability: a population study of older Italians
.
Am J Geriatr Psychiatry
.
2007 Aug
;
15
(
8
):
716
24
. .
3.
Liu-Seifert
H
,
Siemers
E
,
Price
K
,
Han
B
,
Selzler
KJ
,
Henley
D
,
Cognitive impairment precedes and predicts functional impairment in mild Alzheimer's disease
.
J Alzheimers Dis
.
2015
;
47
(
1
):
205
14
. .
4.
Bassuk
SS
,
Wypij
D
,
Berkman
LF
.
Cognitive impairment and mortality in the community-dwelling elderly
.
Am J Epidemiol
.
2000 Apr 1
;
151
(
7
):
676
88
. .
5.
Plassman
BL
,
Langa
KM
,
Fisher
GG
,
Heeringa
SG
,
Weir
DR
,
Ofstedal
MB
,
Prevalence of cognitive impairment without dementia in the United States
.
Ann Intern Med
.
2008 Mar 18
;
148
(
6
):
427
34
. .
6.
Lezak
MD
,
Howieson
DB
,
Loring
DW
,
Hannay
HJ
,
Fischer
JS
.
Neuropsychological assessment
. 4th ed.
New York
:
Oxford University Press
;
2004
.
7.
Amieva
H
,
Le Goff
M
,
Millet
X
,
Orgogozo
JM
,
Pérès
K
,
Barberger-Gateau
P
,
Prodromal Alzheimer's disease: successive emergence of the clinical symptoms
.
Ann Neurol
.
2008 Nov
;
64
(
5
):
492
8
. .
8.
Wilson
RS
,
Leurgans
SE
,
Boyle
PA
,
Bennett
DA
.
Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment
.
Arch Neurol
.
2011 Mar
;
68
(
3
):
351
6
. .
9.
Salthouse
TA
.
Selective review of cognitive aging
.
J Int Neuropsychol Soc
.
2010 Sep
;
16
(
5
):
754
60
. .
10.
Salthouse
TA
.
Trajectories of normal cognitive aging
.
Psychol Aging
.
2019 Feb
;
34
(
1
):
17
24
. .
11.
Singh-Manoux
A
,
Kivimaki
M
,
Glymour
MM
,
Elbaz
A
,
Berr
C
,
Ebmeier
KP
,
Timing of onset of cognitive decline: results from Whitehall II prospective cohort study
.
BMJ
.
2012
;
344
:
d7622
. .
12.
van Gelder
BM
,
Tijhuis
MA
,
Kalmijn
S
,
Giampaoli
S
,
Kromhout
D
.
Decline in cognitive functioning is associated with a higher mortality risk
.
Neuroepidemiology
.
2007
;
28
(
2
):
93
100
. .
13.
Schupf
N
,
Tang
MX
,
Albert
SM
,
Costa
R
,
Andrews
H
,
Lee
JH
,
Decline in cognitive and functional skills increases mortality risk in nondemented elderly
.
Neurology
.
2005 Oct 25
;
65
(
8
):
1218
26
. .
14.
Wilson
RS
,
Wang
T
,
Yu
L
,
Bennett
DA
,
Boyle
PA
.
Normative cognitive decline in old age
.
Ann Neurol
.
2020 Mar 6
.
15.
Sebastiani
P
,
Andersen
SL
,
Sweigart
B
,
Du
M
,
Cosentino
S
,
Thyagarajan
B
,
Patterns of multi-domain cognitive aging in participants of the Long Life Family Study
.
Geroscience
.
2020 Oct
;
42
(
5
):
1335
50
. .
16.
Wilson
RS
,
Beckett
LA
,
Barnes
LL
,
Schneider
JA
,
Bach
J
,
Evans
DA
,
Individual differences in rates of change in cognitive abilities of older persons
.
Psychol Aging
.
2002 Jun
;
17
(
2
):
179
93
. .
17.
Morse
CK
.
Does variability increase with age? An archival study of cognitive measures
.
Psychol Aging
.
1993 Jun
;
8
(
2
):
156
64
. .
18.
Christensen
H
,
Mackinnon
AJ
,
Korten
AE
,
Jorm
AF
,
Henderson
AS
,
Jacomb
P
,
An analysis of diversity in the cognitive performance of elderly community dwellers: individual differences in change scores as a function of age
.
Psychol Aging
.
1999 Sep
;
14
(
3
):
365
79
. .
19.
Hayden
KM
,
Reed
BR
,
Manly
JJ
,
Tommet
D
,
Pietrzak
RH
,
Chelune
GJ
,
Cognitive decline in the elderly: an analysis of population heterogeneity
.
Age Ageing
.
2011 Nov
;
40
(
6
):
684
9
. .
20.
Poon
LW
,
Woodard
JL
,
Stephen Miller
L
,
Green
R
,
Gearing
M
,
Davey
A
,
Understanding dementia prevalence among centenarians
.
J Gerontol A Biol Sci Med Sci
.
2012 Apr
;
67
(
4
):
358
65
. .
21.
Qiu
C
,
Fratiglioni
L
.
Aging without dementia is achievable: current evidence from epidemiological research
.
J Alzheimers Dis
.
2018
;
62
(
3
):
933
42
. .
22.
Sebastiani
P
,
Sun
FX
,
Andersen
SL
,
Lee
JH
,
Wojczynski
MK
,
Sanders
JL
,
Families enriched for exceptional longevity also have increased health-span: findings from the Long Life Family Study
.
Front Public Health
.
2013
;
1
:
38
. .
23.
Ash
AS
,
Kroll-Desrosiers
AR
,
Hoaglin
DC
,
Christensen
K
,
Fang
H
,
Perls
TT
.
Are members of long-lived families healthier than their equally long-lived peers? Evidence from the long life family study
.
J Gerontol A Biol Sci Med Sci
.
2015 Aug
;
70
(
8
):
971
6
. .
24.
Pahlen
S
,
Hamdi
NR
,
Dahl Aslan
AK
,
Horwitz
BN
,
Panizzon
MS
,
Petersen
I
,
Age-moderation of genetic and environmental contributions to cognitive functioning in mid- and late-life for specific cognitive abilities
.
Intelligence
.
2018 May-Jun
;
68
:
70
81
. .
25.
Lipton
RB
,
Hirsch
J
,
Katz
MJ
,
Wang
C
,
Sanders
AE
,
Verghese
J
,
Exceptional parental longevity associated with lower risk of Alzheimer's disease and memory decline
.
J Am Geriatr Soc
.
2010 Jun
;
58
(
6
):
1043
9
. .
26.
Murabito
JM
,
Beiser
AS
,
Decarli
C
,
Seshadri
S
,
Wolf
PA
,
Au
R
.
Parental longevity is associated with cognition and brain ageing in middle-aged offspring
.
Age Ageing
.
2014 May
;
43
(
3
):
358
63
. .
27.
Andersen
SL
,
Sweigart
B
,
Sebastiani
P
,
Drury
J
,
Sidlowski
S
,
Perls
TT
.
Reduced prevalence and incidence of cognitive impairment among centenarian offspring
.
J Gerontol A Biol Sci Med Sci
.
2019 Jan 1
;
74
(
1
):
108
13
. .
28.
Newman
AB
,
Glynn
NW
,
Taylor
CA
,
Sebastiani
P
,
Perls
TT
,
Mayeux
R
,
Health and function of participants in the Long Life Family Study: a comparison with other cohorts
.
Aging (Albany NY)
.
2011 Jan
;
3
(
1
):
63
76
. .
29.
Cosentino
S
,
Schupf
N
,
Christensen
K
,
Andersen
SL
,
Newman
A
,
Mayeux
R
.
Reduced prevalence of cognitive impairment in families with exceptional longevity
.
JAMA Neurol
.
2013 Jul
;
70
(
7
):
867
74
. .
30.
Barral
S
,
Cosentino
S
,
Costa
R
,
Matteini
A
,
Christensen
K
,
Andersen
SL
,
Cognitive function in families with exceptional survival
.
Neurobiol Aging
.
2012 Mar
;
33
(
3
):
619
7
. .
31.
Sebastiani
P
,
Hadley
EC
,
Province
M
,
Christensen
K
,
Rossi
W
,
Perls
TT
,
A family longevity selection score: ranking sibships by their longevity, size, and availability for study
.
Am J Epidemiol
.
2009 Dec 15
;
170
(
12
):
1555
62
. .
32.
Wechsler
D
.
Wechsler memory scale - revised (WMS-R)
.
San Antonio
:
The Psychological Corp.
;
1987
.
33.
Wechsler
D
.
WAIS-R : Wechsler adult intelligence scale-revised
.
San Antonio, TX
:
Psychological Corporation
;
1981
.
34.
Strauss
E
,
Sherman
EMS
,
Spreen
O
.
A compendium of neuropsychological tests: administration, norms, and commentary
. 3rd ed.
New York
:
Oxford University Press
;
2006
.
35.
Folstein
MF
,
Folstein
SE
,
McHugh
PR
.
Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
.
J Psychiatr Res
.
1975 Nov
;
12
(
3
):
189
98
.
36.
Sun
F
,
Sebastiani
P
,
Schupf
N
,
Bae
H
,
Andersen
SL
,
McIntosh
A
,
Extended maternal age at birth of last child and women's longevity in the Long Life Family Study
.
Menopause
.
2015 Jan
;
22
(
1
):
26
31
. .
37.
Stijntjes
M
,
de Craen
AJ
,
van Heemst
D
,
Meskers
CG
,
van Buchem
MA
,
Westendorp
RG
,
Familial longevity is marked by better cognitive performance at middle age: the Leiden Longevity Study
.
PLoS One
.
2013
;
8
(
3
):
e57962
. .
38.
Dutta
A
,
Henley
W
,
Robine
JM
,
Llewellyn
D
,
Langa
KM
,
Wallace
RB
,
Aging children of long-lived parents experience slower cognitive decline
.
Alzheimers Dement
.
2014 Oct
;
10
(
5 Suppl
):
S315
22
. .
39.
Proust-Lima
C
,
Amieva
H
,
Dartigues
JF
,
Jacqmin-Gadda
H
.
Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies
.
Am J Epidemiol
.
2007 Feb 1
;
165
(
3
):
344
50
. .
40.
Jaeger
J
.
Digit symbol substitution test: the case for sensitivity over specificity in neuropsychological testing
.
J Clin Psychopharmacol
.
2018 Oct
;
38
(
5
):
513
9
. .
41.
Pavlik
VN
,
de Moraes
SA
,
Szklo
M
,
Knopman
DS
,
Mosley
TH
 Jr.
,
Hyman
DJ
.
Relation between cognitive function and mortality in middle-aged adults: the atherosclerosis risk in communities study
.
Am J Epidemiol
.
2003 Feb 15
;
157
(
4
):
327
34
. .
42.
Duff
K
,
Mold
JW
,
Gidron
Y
.
Cognitive functioning predicts survival in the elderly
.
J Clin Exp Neuropsychol
.
2009 Jan
;
31
(
1
):
90
5
. .
43.
Aichele
S
,
Rabbitt
P
,
Ghisletta
P
.
Think fast, feel fine, live long: a 29-year study of cognition, health, and survival in middle-aged and older adults
.
Psychol Sci
.
2016 Apr
;
27
(
4
):
518
29
. .
44.
Wettstein
M
,
Spuling
SM
,
Cengia
A
.
Trajectories of functional health and its associations with information processing speed and subjective well-being: the role of age versus time to death
.
Psychol Aging
.
2020 Mar
;
35
(
2
):
190
203
. .
45.
Small
BJ
,
Dixon
RA
,
McArdle
JJ
.
Tracking cognition-health changes from 55 to 95 years of age
.
J Gerontol B Psychol Sci Soc Sci
.
2011 Jul
;
66
(
Suppl 1
):
i153
61
. .
46.
Ritchie
SJ
,
Tucker-Drob
EM
,
Cox
SR
,
Corley
J
,
Dykiert
D
,
Redmond
P
,
Predictors of ageing-related decline across multiple cognitive functions
.
Intelligence
.
2016 Nov-Dec
;
59
:
115
26
. .
47.
Woodard
JL
.
A quarter century of advances in the statistical analysis of longitudinal neuropsychological data
.
Neuropsychology
.
2017 Nov
;
31
(
8
):
1020
35
. .
48.
Schwartz
CR
,
Mare
RD
.
Trends in educational assortative marriage from 1940 to 2003
.
Demography
.
2005 Nov
;
42
(
4
):
621
46
. .
49.
Sebastiani
P
,
Gurinovich
A
,
Bae
H
,
Andersen
SL
,
Perls
TT
.
Assortative mating by ethnicity in longevous families
.
Front Genet
.
2017 Nov 21
;
8
(
186
):
186
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.